National Hog Farmer is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Boehringer Ingelheim documents progress in PRRS Knowledge Manual

Boehringer Ingelheim PRRS Knowledge Manual Cover.png
Details the three core pillars of PRRS control: maximize immunity, minimize exposure/transmission and measure and monitor with diagnostics. 

Boehringer Ingelheim has announced the launch of the PRRS Knowledge Manual, a handbook chronicling 25-plus years of porcine reproductive and respiratory syndrome virus research and best practices for control. 

Compiling collaborative research and global perspectives from a variety of sources across academia and swine production, the PRRS Knowledge Manual offers one of the industry's most comprehensive overviews of PRRSV history, immunology, as well as practical advice for prevention and control. Chapter topics include: 

  • Foundations of PRRS – Information related to PRRSV immunity and the economic impact of the virus. 
  • Principles of PRRS Control – Detailing the three core pillars of PRRS control: maximize immunity, minimize exposure/transmission and measure and monitor with diagnostics. 
  • The Role of Vaccine-Derived Immunity – Outlining the direct and indirect benefits of vaccination.
  • Implementation of PRRS Control Strategies – Best practices for control, including the 5-Step Process and Infection Chain methodologies created by Boehringer Ingelheim. 

"We have made tremendous strides in PRRS management over the last 25 years, none of which would have been possible without the dedication of academic researchers, veterinarians and producers in the field," said Reid Philips, DVM, Technical Manager for PRRS at Boehringer Ingelheim U.S. Swine Division. "We are proud to collaborate with these groups to bridge knowledge gaps and advance PRRS control strategies, in turn improving health and performance of pigs and the bottom line for producers."

As has been true for many years, PRRS is still the most economically significant disease affecting the U.S. swine industry1 with economic losses from PRRS estimated at $664 million annually, or $1.8 million per day.2 Continuous, collaborative research has proven critical to advancing the industry's ability to manage this devastating virus. 

"As the company that brought the industry's first modified-live PRRS vaccine to market, Boehringer Ingelheim is committed to continuing its legacy in PRRS protection," said Lara Sheeley, executive director of Swine and Poultry Divisions at Boehringer Ingelheim. "The PRRS Knowledge Manual is a milestone in this legacy, documenting more than 25 years of progress in PRRS management, but also celebrating the community of industry professionals who made that progress possible."

To download a free copy of the PRRS Knowledge Manual visit the website.

1 Iowa State University College of Veterinary Medicine website. Porcine reproductive and respiratory syndrome (PRRS). Available here. Accessed July 7, 2019. 
2 Holtkamp DJ, Kliebenstein JB, Neumann EJ, et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on U.S. pork producers. J Swine Health Prod 2013;21(2):72–84.

Source: Boehringer Ingelheim, which is solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset. 

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.